【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value chain analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: CUSTOMER LANDSCAPE
PART 07: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 08: MARKET SEGMENTATION BY INDICATION
• Market segmentation by indication
• Comparison by indication
• Atopic dermatitis – Market size and forecast 2019-2024
• Contact dermatitis – Market size and forecast 2019-2024
• Other indication – Market size and forecast 2019-2024
• Market opportunity by indication
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Business strategies
• Geopolitical uncertainties
• Increasing healthcare expenditure
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie Inc.
• Alliance Pharma Plc
• Bausch Health Companies Inc.
• Bayer AG
• Eli Lilly and Co.
• Encore Dermatology Inc.
• LEO Pharma AS
• Mylan NV
• Pfizer Inc.
• Sanofi
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key Offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Customer landscape
Exhibit 19: Market share by geography 2019-2024 (%)
Exhibit 20: Geographic comparison
Exhibit 21: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 22: North America – Year-over-year growth 2020-2024 (%)
Exhibit 23: Top 3 countries in North America
Exhibit 24: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 26: Top 3 countries in Europe
Exhibit 27: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 28: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 29: Top 3 countries in Asia
Exhibit 30: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 32: Top 3 countries in ROW
Exhibit 33: Key leading countries
Exhibit 34: Market opportunity
Exhibit 35: Indication – Market share 2019-2024 (%)
Exhibit 36: Comparison by indication
Exhibit 37: Atopic dermatitis – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: Atopic dermatitis – Year-over-year growth 2020-2024 (%)
Exhibit 39: Contact dermatitis – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: Contact dermatitis – Year-over-year growth 2020-2024 (%)
Exhibit 41: Other indication – Market size and forecast 2019-2024 ($ millions)
Exhibit 42: Other indication – Year-over-year growth 2020-2024 (%)
Exhibit 43: Market opportunity by indication
Exhibit 44: Product launch details
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Business strategies
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: AbbVie Inc. – Vendor overview
Exhibit 53: AbbVie Inc. – Business segments
Exhibit 54: AbbVie Inc. – Organizational developments
Exhibit 55: AbbVie Inc. – Geographic focus
Exhibit 56: AbbVie Inc. – Key offerings
Exhibit 57: AbbVie Inc. – Key customers
Exhibit 58: Alliance Pharma Plc – Vendor overview
Exhibit 59: Alliance Pharma Plc – Business segments
Exhibit 60: Alliance Pharma Plc – Organizational developments
Exhibit 61: Alliance Pharma Plc – Geographic focus
Exhibit 62: Alliance Pharma Plc – Segment focus
Exhibit 63: Alliance Pharma Plc – Key offerings
Exhibit 64: Alliance Pharma Plc – Key customers
Exhibit 65: Bausch Health Companies Inc. – Vendor overview
Exhibit 66: Bausch Health Companies Inc. – Business segments
Exhibit 67: Bausch Health Companies Inc. – Organizational developments
Exhibit 68: Bausch Health Companies Inc. – Geographic focus
Exhibit 69: Bausch Health Companies Inc. – Segment focus
Exhibit 70: Bausch Health Companies Inc. – Key offerings
Exhibit 71: Bausch Health Companies Inc. – Key customers
Exhibit 72: Bayer AG – Vendor overview
Exhibit 73: Bayer AG – Business segments
Exhibit 74: Bayer AG – Organizational developments
Exhibit 75: Bayer AG – Geographic focus
Exhibit 76: Bayer AG – Segment focus
Exhibit 77: Bayer AG – Key offerings
Exhibit 78: Bayer AG – Key customers
Exhibit 79: Eli Lilly and Co. – Vendor overview
Exhibit 80: Eli Lilly and Co. – Business segments
Exhibit 81: Eli Lilly and Co. – Organizational developments
Exhibit 82: Eli Lilly and Co. – Geographic focus
Exhibit 83: Eli Lilly and Co. – Segment focus
Exhibit 84: Eli Lilly and Co. – Key offerings
Exhibit 85: Eli Lilly and Co. – Key customers
Exhibit 86: Encore Dermatology Inc. – Vendor overview
Exhibit 87: Encore Dermatology Inc. – Product segments
Exhibit 88: Encore Dermatology Inc. – Organizational developments
Exhibit 89: Encore Dermatology Inc. – Key offerings
Exhibit 90: Encore Dermatology Inc. – Key customers
Exhibit 91: LEO Pharma AS – Vendor overview
Exhibit 92: LEO Pharma AS – Product segments
Exhibit 93: LEO Pharma AS – Organizational developments
Exhibit 94: LEO Pharma AS – Key offerings
Exhibit 95: LEO Pharma AS – Key customers
Exhibit 96: Mylan NV – Vendor overview
Exhibit 97: Mylan NV – Product segments
Exhibit 98: Mylan NV – Organizational developments
Exhibit 99: Mylan NV – Geographic focus
Exhibit 100: Mylan NV – Segment focus
Exhibit 101: Mylan NV – Key offerings
Exhibit 102: Mylan NV – Key customers
Exhibit 103: Pfizer Inc. – Vendor overview
Exhibit 104: Pfizer Inc. – Business segments
Exhibit 105: Pfizer Inc. – Organizational developments
Exhibit 106: Pfizer Inc. – Geographic focus
Exhibit 107: Pfizer Inc. – Segment focus
Exhibit 108: Pfizer Inc. – Key offerings
Exhibit 109: Pfizer Inc. – Key customers
Exhibit 110: Sanofi – Vendor overview
Exhibit 111: Sanofi – Business segments
Exhibit 112: Sanofi – Organizational developments
Exhibit 113: Sanofi – Geographic focus
Exhibit 114: Sanofi – Segment focus
Exhibit 115: Sanofi – Key offerings
Exhibit 116: Sanofi – Key customers
Exhibit 117: Validation techniques employed for market sizing
Exhibit 118: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：湿疹治療薬の世界市場：疾患別、地域別■ 英文：Eczema Therapeutics Market by Indication and Geography - Forecast and Analysis 2020-2024
■ 発行日：2019年12月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR40707
■ 調査対象地域：グローバル
- 世界の放射性医薬品市場2015The Global Radiopharmaceuticals Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Radiopharmaceuticals industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Radiopharmaceuticals market analysis is provided for the international markets including develop …
- 頸動脈狭窄症(Carotid Artery Stenosis)：世界の治験レビュー（2015年上半期版）Carotid Artery Stenosis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Carotid Artery Stenosis Global Clinical Trials Review, H1, 2015" provides data on the Carotid Artery Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Carotid Artery Stenosis. It includes an overview of the trial numbers …
- ヨーロッパの押出コーティング用生分解性ポリマー市場：種類別（PLA、澱粉、PBS、PHA）、基材別（紙および板紙、セルロースフィルム）、用途別（リジッド包装、フレキシブル包装、液体包装）、国家別Increasing demand from various packaging applications is expected to drive the biodegradable polymers market for extrusion coating. The European biodegradable polymers market for extrusion coating size is expected to grow from USD 403 million in 2019 to USD 829 million by 2024, at a CAGR of 15.5% during the forecast period. The biodegradable polymers market for extrusion coating is driven by vario …
- スマートヘルスケアソリューションの世界市場：EHR、遠隔医療、mヘルス、スマートピルAbout Smart HealthcareSmart healthcare is the integration of different healthcare delivery mechanisms. It makes use of electronic patient records and streamlining processes, which leads to improved quality of life by reducing the risks to health (by remote monitoring and checks) and improving the general well-being of people. Smart healthcare provides more patient-centric services that improves ac …
- キーレスエントリーシステムの世界市場ABSTRACTAbout Keyless Entry Systems Keyless entry systems are systems that provide physical access to a premise without using a mechanical key to perform locking and unlocking operations. These systems provide enhanced security and convenience for users. Users get authorized and secure access to a premise by using a device such as a smart card or a keyless fob, or by using their own fingerprints, …
- 中東（GCC）の消火器市場2016-2020About GCC Fire Extinguisher The rising levels of urbanization, supported by infrastructure development projects in the GCC, is the key growth driver behind the demand for fire extinguishers. The Civil defense department in GCC has also laid down guidelines that the building owners need to follow while operating different types of buildings. The Occupational Health and Safety Administration (OSHA) …
- TEVAR（胸部大動脈瘤ステントグラフト治療）の世界市場2016-2020About thoracic endovascular aneurysm repair (TEVAR) TEVAR is a minimally invasive procedure done to repair thoracic aortic aneurysms (TAAs) with reduced recovery time and improved survival rates. TAAs are usually asymptomatic, but can lead to life-threatening hemorrhage and rupture. It is divided into three categories based on the location of the problem: aortic arch, ascending aortic, and descend …
- 自動車ウォッシャポンプの世界市場2017-2021About Automotive Washer Pumps Automotive washer pumps are used in almost every passenger and commercial vehicle. They provide clear visibility to the driver by cleaning the windshield and headlamp glasses. The high pressure needed to clean the dust or dirt from the glass is generated by washer pumps. A typical automotive washer pump has a cylindrical structure with a port for connecting hoses. The …
- Energen Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Energen Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Energen Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- Laredo Petroleum Holdings：石油・ガスの開発・生産動向及びコスト分析- 2012Laredo Petroleum Holdings Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Laredo Petroleum Holdings Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- グリーンキレート/天然キレート剤の世界市場：グルコン酸ナトリウム、EDDS、MGDA、GLADThe market size of green chelates/natural chelating agents is projected to reach USD 2.45 Billion by 2021, registering a CAGR of 5.74% between 2016 and 2021. The increasing demand for green chelates/natural chelating agents from end-use applications such as cleaning, water treatment, agriculture, personal care, and food & beverage owing to its superior properties and eco-friendliness is the major …
- 建物・建設産業向けナノコーティング剤の世界市場2017-2021About nanocoatings Nanocoatings coat surfaces with nanostructures that form a uniform network of molecules. The thickness of these coatings is measured in nanoscales. Technavio’s analysts forecast the global nanocoatings market for the building and construction industry to grow at a CAGR of 20.41% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the …
- MarkWest Energy Partners, L.P.：石油・ガスバリューチェーン分析レポート2013MarkWest Energy Partners, L.P. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "MarkWest Energy Partners, L.P." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “MarkWest Energy Partners, L.P.”. The report provides key information relating to oil and gas assets of the company along with its operations across th …
- Vermilion Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Vermilion Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Vermilion Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- Tachycardia (Tachyarrhythmias)：グローバル臨床試験レビューH1, 2013Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2013" provides data on the Tachycardia (Tachyarrhythmias) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tachycardia (Tachyarrhythmias). It includes an o …
